.After antibody-drug conjugate (ADC) specialist Seagen was sold to Pfizer in 2014 for a monstrous $4...
.On the heels of a phase 3 succeed that failed to thrill financiers, Ironwood Pharmaceuticals is act...
.Don't stop Monte Rosa Therapeutics currently. The Boston-based biotech is actually having a ball af...
.Welcome to recently's Chutes & Ladders, our summary of substantial leadership hirings, firings a...
.Commemorating his business's upsized going public (IPO), Septerna chief executive officer Jeffrey F...
.AbbVie has actually come back to the source of its own antipsychotic goliath Vraylar trying to find...
.GenSight Biologics is actually full weeks out of losing cash. Again. The biotech only has adequate ...
.Monopar Rehabs is actually recouping a medication from the scrap heap of AstraZeneca's uncommon ill...
.With brand-new data out on Arcus Biosciences' speculative HIF-2a inhibitor, one group of analysts e...
.After developing a genetics treatment relationship along with Dyno Therapies in 2020, Roche is back...